Skip to main content
SpringerLink
Log in

Novel Therapies in Critically Ill Septic Patients

  • Chapter
Sepsis

  • 1166 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bone RC, Fisher CJJ, Clemmer TP, et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987;317:653–8.

    Article  PubMed  CAS  Google Scholar 

  2. The Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987;317:659–65.

    Article  Google Scholar 

  3. Bollaert PE, Charpentier C, Levy B, et al. Reversal of late septic shock with supra-physiologic doses of hydrocortisone. Crit Care Med 1998;26:645–50.

    Article  PubMed  CAS  Google Scholar 

  4. Briegel J, Forst H, Haller M, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999;27:723–32.

    Article  PubMed  CAS  Google Scholar 

  5. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288:862–71.

    Article  PubMed  CAS  Google Scholar 

  6. Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858–73.

    Article  PubMed  Google Scholar 

  7. Amaral A, Opal SM, Vincent JL. Coagulation in sepsis. Intensive Care Med 2004;30:1032–40.

    Article  PubMed  Google Scholar 

  8. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699–709.

    Article  PubMed  CAS  Google Scholar 

  9. Vincent JL, Angus DC, Artigas A, et al. Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med 2003;31:834–40.

    Article  PubMed  CAS  Google Scholar 

  10. Bernard GR, Macias WL, Joyce DE, et al. Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis. Crit Care 2003;7:155–63.

    Article  PubMed  Google Scholar 

  11. Vincent JL, Levy MM, Macias WL, et al. Early intervention with drotrecogin alfa (activated) improves survival benefit. Crit Care Med 2003;3:834–40.

    Article  Google Scholar 

  12. Manns BJ, Lee H, Doig CJ, et al. An economic evaluation of activated protein C treatment for severe sepsis. N Engl J Med 2002;347:993–1000.

    Article  PubMed  Google Scholar 

  13. Angus DC, Linde-Zwirble WT, Clermont G, et al. Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis. Crit Care Med 2003;31:1–11.

    Article  PubMed  Google Scholar 

  14. Cole L, Bellomo R, Hart G, et al. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002;30:100–6.

    Article  PubMed  CAS  Google Scholar 

  15. Ronco C, Brendolan A, Lonnemann G, et al. A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 2002;30:1250–5.

    Article  PubMed  Google Scholar 

  16. Formica M, Olivieri C, Livigni S, et al. Hemodynamic response to coupled plasma-filtration-adsorption in human septic shock. Intensive Care Med 2003;29:703–8.

    PubMed  Google Scholar 

  17. Gordon BR, Parker TS, Levine DM, et al. Low lipid concentrations in critical illness: implications for preventing and treating endotoxemia. Crit Care Med 1996;24:584–9.

    Article  PubMed  CAS  Google Scholar 

  18. van Leeuwen HJ, Heezius EC, Dallinga GM, et al. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 2003;31:1359–66.

    Article  PubMed  CAS  Google Scholar 

  19. Pajkrt D, Doran JE, Koster F, et al. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia. J Exp Med 1996;184:1601–8.

    Article  PubMed  CAS  Google Scholar 

  20. Cue JI, DiPiro JT, Brunner LJ, et al. Reconstituted high density lipoprotein inhibits physiologic and tumor necrosis factor alpha responses to lipopolysaccharide in rabbits. Arch Surg 1994;129:193–7.

    PubMed  CAS  Google Scholar 

  21. Goldfarb RD, Parker TS, Levine DM, et al. Protein-free phospholipid emulsion treatment improved cardiopulmonary function and survival in porcine sepsis. Am J Physiol Regul Integr Comp Physiol 2003;284:R550–7.

    PubMed  Google Scholar 

  22. Hotchkiss RS, Chang KC, Swanson PE, et al. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol 2000;1:496–501.

    Article  PubMed  CAS  Google Scholar 

  23. Hotchkiss RS, Tinsley KW, Swanson PE, et al. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci USA 1999;96:14541–6.

    Article  PubMed  CAS  Google Scholar 

  24. Chung CS, Song GY, Lomas J, et al. Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity. J Leukoc Biol 2003;74:344–51.

    Article  PubMed  CAS  Google Scholar 

  25. Weaver JG, Rouse MS, Steckelberg JM, et al. Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis. FASEB J 2004;18:1185–91.

    Article  PubMed  CAS  Google Scholar 

  26. Yang H, Ochani M, Li J, Qiang X, et al. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci USA 2004;101:296–301.

    Article  PubMed  CAS  Google Scholar 

  27. Ulloa L, Ochani M, Yang H, et al. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci USA 2002;99:12351–6.

    Article  PubMed  CAS  Google Scholar 

  28. Pacher P, Cziraki A, Mabley JG, et al. Role of poly(ADP-ribose) polymerase activation in endotoxin-induced cardiac collapse in rodents. Biochem Pharmacol 2002;64:1785–91.

    Article  PubMed  CAS  Google Scholar 

  29. Lopez A, Lorente JA, Steingrub J, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004;32:21–30.

    Article  PubMed  CAS  Google Scholar 

  30. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368–77.

    Article  PubMed  CAS  Google Scholar 

  31. Malay MB, Ashton RC, Jr., Landry DW, et al. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999;47:699–703.

    Article  PubMed  CAS  Google Scholar 

  32. Patel BM, Chittock DR, Russell JA, et al. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002;96:576–82.

    Article  PubMed  CAS  Google Scholar 

  33. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patient. N Engl J Med 2001;345:1359–67.

    Article  PubMed  Google Scholar 

  34. Van den B G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003;31:359–66.

    Article  CAS  Google Scholar 

  35. Finney SJ, Zekveld C, Elia A, et al. Glucose control and mortality in critically ill patients. JAMA 2003;290:2041–7.

    Article  PubMed  CAS  Google Scholar 

  36. Laver S, Preston S, Turner D, et al. Implementing intensive insulin therapy: development and audit of the bath insulin protocol. Anaesth Intensive Care 2004;32:311–6.

    PubMed  CAS  Google Scholar 

  37. Kanji S, Singh A, Tierney M, et al. Standardization of intravenous insulin therapy improves the efficiency and safety of blood glucose control in critically ill adults. Intensive Care Med 2004;30:804–10.

    Article  PubMed  Google Scholar 

  38. Galban C, Montejo JC, Mesejo A, et al. An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients. Crit Care Med 2000;28:643–8.

    Article  PubMed  CAS  Google Scholar 

  39. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250–6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Intensive Care, Erasme Hospital, Free University of Brussels, Belgium

    Jean-Louis Vincent MD, PhD, FCCP (Professor), Carla Marie Clausi MD & Alejandro Bruhn MD

Authors
  1. Jean-Louis Vincent MD, PhD, FCCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carla Marie Clausi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alejandro Bruhn MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pulmonary and Critical Care Medicine, Universidad del Bosque, Bogotá, Colombia

    Guillermo Ortiz-Ruiz MD

  2. Intensive Care Unit, Fundacion Clinica Shaio, Bogotá, Colombia

    Marco A. Perafán MD

  3. Department of Surgery Klinikum Grosshadern, University of Munich, Munich, Germany

    Eugen Faist MD

  4. Pulmonary and Critical Care Medicine, Hospital Bocagrande, Cartagena, Colombia

    Carmelo Dueñas Castell MD

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Vincent, JL., Clausi, C.M., Bruhn, A. (2006). Novel Therapies in Critically Ill Septic Patients. In: Ortiz-Ruiz, G., Perafán, M.A., Faist, E., Castell, C.D. (eds) Sepsis. Springer, New York, NY. https://doi.org/10.1007/0-387-34574-4_3

Download citation

  • DOI: https://doi.org/10.1007/0-387-34574-4_3

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-29816-0

  • Online ISBN: 978-0-387-34574-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation